title: Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis.
abstract: Glutamate is the main excitatory neurotransmitter in the mammalian brain. Appropriate transmission of nerve impulses through glutamatergic synapses is required throughout the brain and forms the basis of many processes including learning and memory. However, abnormally high levels of extracellular brain glutamate can lead to neuroaxonal cell death. We have previously reported elevated glutamate levels in the brains of patients suffering from multiple sclerosis. Here two complementary analyses to assess the extent of genomic control over glutamate levels were used. First, a genome-wide association analysis in 382 patients with multiple sclerosis using brain glutamate concentration as a quantitative trait was conducted. In a second approach, a protein interaction network was used to find associated genes within the same pathway. The top associated marker was rs794185 (P < 6.44 x 10(-7)), a non-coding single nucleotide polymorphism within the gene sulphatase modifying factor 1. Our pathway approach identified a module composed of 70 genes with high relevance to glutamate biology. Individuals carrying a higher number of associated alleles from genes in this module showed the highest levels of glutamate. These individuals also showed greater decreases in N-acetylaspartate and in brain volume over 1 year of follow-up. Patients were then stratified by the amount of annual brain volume loss and the same approach was performed in the 'high' (n = 250) and 'low' (n = 132) neurodegeneration groups. The association with rs794185 was highly significant in the group with high neurodegeneration. Further, results from the network-based pathway analysis remained largely unchanged even after stratification. Results from these analyses indicated that variance in the activity of neurochemical pathways implicated in neurodegeneration is explained, at least in part, by the inheritance of common genetic polymorphisms. Spectroscopy-based imaging provides a novel quantitative endophenotype for genetic association studies directed towards identifying new factors that contribute to the heterogeneity of clinical expression of multiple sclerosis.
authors.affiliation: Department of Neurology, School of Medicine, University of California-San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143-0435, USA. sebaran@cgl.ucsf.edu
authors.forename: Sergio E
authors.initials: SE
authors.lastname: Baranzini
authors.forename: Radhika
authors.initials: R
authors.lastname: Srinivasan
authors.forename: Pouya
authors.initials: P
authors.lastname: Khankhanian
authors.forename: Darin T
authors.initials: DT
authors.lastname: Okuda
authors.forename: Sarah J
authors.initials: SJ
authors.lastname: Nelson
authors.forename: Paul M
authors.initials: PM
authors.lastname: Matthews
authors.forename: Stephen L
authors.initials: SL
authors.lastname: Hauser
authors.forename: Jorge R
authors.initials: JR
authors.lastname: Oksenberg
authors.forename: Daniel
authors.initials: D
authors.lastname: Pelletier
mesh_terms: D000328:Adult; D001224:Aspartic Acid / Q000031:analogs & derivatives / Q000378:metabolism; D001921:Brain / Q000378:metabolism*; D003198:Computer Simulation; D005260:Female; D005500:Follow-Up Studies; D005787:Gene Frequency; D014644:Genetic Variation / Q000235:genetics*; D055106:Genome-Wide Association Study / Q000379:methods; D005838:Genotype; D018698:Glutamic Acid / Q000378:metabolism*; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D008875:Middle Aged; D008957:Models, Genetic; D009103:Multiple Sclerosis / Q000235:genetics* / Q000473:pathology*; D050862:Oxidoreductases Acting on Sulfur Group Donors; D020641:Polymorphism, Single Nucleotide / Q000235:genetics; D013223:Statistics as Topic; D013429:Sulfatases / Q000235:genetics*
chemical_list: D001224:Aspartic Acid; D018698:Glutamic Acid; C000179:N-acetylaspartate; D050862:Oxidoreductases Acting on Sulfur Group Donors; C480483:SUMF1 protein, human; D013429:Sulfatases
references.citation: Nat Rev Genet. 2006 Nov;7(11):829-40
references.pmid: 17033627
references.citation: J Neurosci. 1996 Jul 1;16(13):4080-8
references.pmid: 8753870
references.citation: Nature. 2005 Dec 22;438(7071):1167-71
references.pmid: 16372012
references.citation: Hum Mol Genet. 2009 Feb 15;18(4):767-78
references.pmid: 19010793
references.citation: Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10930-5
references.pmid: 11535829
references.citation: Neuroimage. 2002 Sep;17(1):479-89
references.pmid: 12482100
references.citation: Nat Genet. 2009 Nov;41(11):1191-8
references.pmid: 19862010
references.citation: Biochem J. 2007 Apr 15;403(2):305-12
references.pmid: 17206939
references.citation: Brain. 2004 Jun;127(Pt 6):1353-60
references.pmid: 15130950
references.citation: Bioinformatics. 2002;18 Suppl 1:S233-40
references.pmid: 12169552
references.citation: Neuroimage. 2006 May 1;30(4):1171-8
references.pmid: 16431138
references.citation: Neuroimage. 2010 Nov 15;53(3):1051-63
references.pmid: 20100581
references.citation: Am J Hum Genet. 2002 Oct;71(4):877-92
references.pmid: 12145742
references.citation: MAGMA. 2007 Jun;20(3):143-55
references.pmid: 17602253
references.citation: Circ Cardiovasc Genet. 2009 Apr;2(2):125-33
references.pmid: 20031576
references.citation: Brain. 2008 Dec;131(Pt 12):3118-31
references.pmid: 18490360
references.citation: Nat Genet. 2009 Jul;41(7):824-8
references.pmid: 19525955
references.citation: Acta Pharmacol Sin. 2009 Apr;30(4):379-87
references.pmid: 19343058
references.citation: Neurosci Lett. 1991 Dec 9;133(2):159-62
references.pmid: 1687755
references.citation: Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18326-31
references.pmid: 17110447
references.citation: Ann Neurol. 2009 Feb;65(2):160-6
references.pmid: 19224531
references.citation: Neuroreport. 2009 Jul 15;20(11):1019-22
references.pmid: 19483657
references.citation: Brain Res Rev. 2008 Mar;57(2):506-19
references.pmid: 17597219
references.citation: Genomics. 2008 Nov;92(5):265-72
references.pmid: 18722519
references.citation: Am J Hum Genet. 2007 Dec;81(6):1278-83
references.pmid: 17966091
references.citation: Neuropsychopharmacology. 2004 Jul;29(7):1353-62
references.pmid: 15054476
references.citation: Hum Mol Genet. 2009 Jun 1;18(11):2078-90
references.pmid: 19286671
references.citation: Eur J Neurosci. 2005 May;21(9):2329-35
references.pmid: 15932592
references.citation: Brain. 2005 May;128(Pt 5):1016-25
references.pmid: 15758036
references.citation: Nature. 2006 Feb 23;439(7079):988-92
references.pmid: 16372019
references.citation: Am J Hum Genet. 2007 Sep;81(3):559-75
references.pmid: 17701901
references.citation: N Engl J Med. 2007 Aug 30;357(9):851-62
references.pmid: 17660530
references.citation: Neurology. 2007 Nov 13;69(20):1942-52
references.pmid: 17998486
references.citation: Nat Med. 2000 Jan;6(1):67-70
references.pmid: 10613826
references.citation: Neuron. 2007 May 24;54(4):583-97
references.pmid: 17521571
references.citation: Brain. 2009 Jan;132(Pt 1):250-9
references.pmid: 19022862
references.citation: J Neurol Sci. 2005 Jun 15;233(1-2):3-13
references.pmid: 15899499
references.citation: Pharmacol Biochem Behav. 2006 Aug;84(4):555-67
references.pmid: 17023038